SavedAdd your journal

Journals / Tüberküloz ve Toraks / 2005 / Cilt: 53 - Sayı: 1

Heparin induced thrombocytopenia: how to manage when the patient is pregnant?

Heparine bağlı trombositopeni: Hasta gebe ise nasıl tedavi edilmeli?

Öner DİKENSOY
Ebru DİKENSOY
Cornelia GRAVES
Richard W. LIGHT
Pages
115–120
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, HIT in general, and special conditions and management issues in pregnant women discussed and the related literature reviewed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Immune mediated heparin induced thrombocytopenia (HIT) remains the most common anti-body mediated, drug-induced thrombocytopenic disorder, and a leading cause of morbidity and mortality.
📊
Key Findings & Data:Management of HIT in pregnant women remains uncertain.
💡
Conclusion & Impact:In this article, HIT in general, and special conditions and management issues in pregnant women discussed and the related literature reviewed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Immune mediated heparin induced thrombocytopenia (HIT) remains the most common anti-body mediated, drug-induced thrombocytopenic disorder, and a leading cause of morbidity and mortality. Management of HIT in pregnant women remains uncertain. In this article, HIT in general, and special conditions and management issues in pregnant women discussed and the related literature reviewed.

Özet

İmmün aracılı heparine bağlı trombositopeni (HBT) antikor aracılı olup, ilaca bağlı oluşan trombositopeni sebepleri arasında en sık görülenidir ve çok ciddi morbidite ve mortaliteye sebep olmaktadır. Bugün için gebelerdeki tedavisi belirsizliğini korumaktadır. Bu makalede genel olarak HBT, gebelerdeki özel durumları ve tedavisi tartışılmış ve ilgili literatür gözden geçirilmiştir.

🔖

Cite This Article

DİKENSOY, Ö., DİKENSOY, E., GRAVES, C., LIGHT, R. W. (2022). Heparin induced thrombocytopenia: how to manage when the patient is pregnant?. Tüberküloz ve Toraks, Cilt: 53 - Sayı: 1, 115–120. https://ajindex.com/articles/619208

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Brieger DB, Mac KH, Marchant KK, Topol EJ. Heparin induced thrombocytopenia. J Am Coll Cardiol 1998; 31: 1449-59
  2. Warkentin TE, Kelton JG. Heparin and platelets. Hematol Oncol Clin North Am 1990; 4: 243-64
  3. Lee DH, Warkentin TE. Frequency of heparin induced thrombocytopenia. In: Warkentin TE, Greinacher A (eds). Heparin Induced Thrombocytopenia. 2nd rev. ed. New York: Marcel Dekker, 2001: 87-121
  4. Warkentin TE, Levine MN, Hirsh J, et al. Heparin induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin. N Engl J Med 1995; 332: 1330-5
  5. Rice L. Heparin induced thrombocytopenia. Arch Intern Med 2004; 164: 1961-4
  6. King DJ, Kelton JG. Heparin-associated thrombocytopenia. Ann Intern Med 1984; 100: 535-40
  7. McCrae KR, Bussel JB, Mannucci PM, et al. Platelets: an update on diagnosis and management of thrombocytopenic disorders. Hematology 2001; 282-305
  8. Vincentin GP, Ford SE, Scott JP, et al. Antibodies from patients with heparin-induced thrombocytopenia are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994; 93: 81-8
  9. Amiral J, Wolf F, Fisher AM, et al. Pathogenicity of IgA and/or IgM antibodies to heparin PF4 complexes in patients with heparin-induced thrombocytopenia. Br J Haematol 1996; 92: 954-9
  10. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention. The seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 311-37
  11. Pouplard C, Lochmann S, Renard B, et al. Induction of monocyte tissue factor expression by antibodies to heparin- platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood 2001; 97: 3300-2
  12. Chong BH. Heparin-induced thrombocytopenia. Aust N ZJ Med 1992; 22: 15-52
  13. Fareed J, Walenga JM, Hoppensteadt DA, et al. Selectins in the HIT syndrome. Pathophysiologic role and therapeutic modulation. Semin Thromb Hemost 1999; 1: 37-42
  14. Silver D, Kapsch DN, Tsoi EKM. Heparin-induced thrombocytopenia, thrombosis and hemorrhage. Ann Surgery 1983; 198: 301-6
  15. Chang JC. White clot syndrome associated with heparin- induced thrombocytopenia: a review of 23 cases. Heart Lung 1987; 16: 403-7
  16. Boshkov LK, Warkentin TE, Hayward CPM, et al. Heparin induced thrombocytopenia and thrombosis: clinical and laboratory studies. Br J Heamatol 1993; 84: 322-8
  17. Laster J, Cikrit D, Walker N, et al. The heparin-induced thrombocyto